INS and type 1 diabetes mellitus: In a 12-week, phase 4 multicenter, randomized, active-controlled, parallel group, open-label study, Dexcom G6 was used to measure TIR when comparing two basal insulin (BI) analogues, insulin glargine 300 U/ml (Gla-300) and insulin degludec 100 U/ml (IDeg-100) in adults with T1D (73).